Marex Group
MRX
71.88
-2.36
-3.18%
Marex Group
US · MRX
#2090 by market cap
Listed 2024
71.88
-2.36
-3.18%
Live - 5344 symbols - heartbeat 379s ago
· 2026-10-07 19:54
After-hours
71.88
0.00%
- Market cap
- 5.17B
- P/E (TTM)i
- 13.36
- P/Bi
- 2.76
- EPSi
- 3.86
- Div yieldi
- 0.85%
- 52W posi
- 85%
Reader sentiment
Are you bullish or bearish on MRX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.40, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +26.93% YoY
Margins
- Gross margin
- 46.99%
- Operating margin
- 32.26%
- Net margin
- 8.10%
Key ratios & quality
- Enterprise valuei
- 8.84B
- PEG ratioi
- 0.29
- Altman Z-Scorei
- 0.40
PEG uses trailing P/E against the 3-year net income growth rate (46.25%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 541.50M | 711.10M | 1.24B | 1.59B | 2.02B |
| Gross profit | 242.20M | 493.60M | 1.03B | 1.29B | 1.71B |
| Selling & admin expenses | 82.50M | 120.10M | 182.10M | 247.10M | 288.80M |
| Research & development | -- | -- | -- | -- | -- |
| Operating profit | 97.40M | 270.50M | 678.30M | 836.30M | 1.17B |
| Pretax profit | 69.90M | 121.60M | 196.50M | 295.80M | 411.60M |
| Tax | 13.40M | 23.40M | 55.20M | 77.80M | 103.70M |
| Net profit | 56.50M | 98.20M | 141.30M | 218.00M | 307.70M |
| Basic EPS | 1 | 1 | 2 | 3 | 4 |
| Diluted EPS | 0.80 | 1.29 | 1.81 | 2.72 | 3.86 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 467.30M | 500.10M | 484.60M | 572.10M | 692.30M | 695.80M |
| Gross profit | 321.00M | 379.50M | 192.60M | 1.14B | 487.90M | 552.90M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 239.30M | 286.10M | 94.60M | 881.80M | 362.50M | 416.90M |
| Pretax profit | 98.00M | 103.60M | 98.80M | 111.20M | 149.80M | 158.20M |
| Tax | 25.50M | 26.90M | 25.60M | 25.70M | 37.50M | 38.30M |
| Net profit | 72.50M | 76.70M | 73.20M | 85.30M | 112.40M | 155.30M |
| Basic EPS | 1 | 1 | 1 | 1 | 2 | 2 |
| Diluted EPS | 0.92 | 0.99 | 0.92 | 1.19 | 1.43 | 2.00 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 4.12B | 15.35B | 16.94B | 23.83B | 33.70B |
| Cash & ST investments | 758.30M | 3.22B | 4.73B | 5.21B | 6.48B |
| Inventory | 80.10M | 35.80M | 163.40M | 35.80M | 483.70M |
| Total assets | 5.26B | 15.74B | 17.61B | 24.31B | 34.68B |
| Total current liabilities | 4.63B | 14.56B | 15.88B | 21.78B | 30.96B |
| Short-term debt | 1.14B | 5.22B | 4.44B | 4.59B | 7.82B |
| Long-term debt | 136.60M | 472.10M | 907.90M | 1.48B | 2.33B |
| Total liabilities | 4,786,900,000.00 | 15,066,200,000.00 | 16,835,700,000.00 | 23,335,600,000.00 | 33,411,500,000.00 |
| Total equity | 477.70M | 677.70M | 775.90M | 976.90M | 1.26B |
| Retained earnings | 346.60M | 455.30M | 555.30M | 722.40M | 982.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 23.78B | 30.41B | 32.13B | 33.70B | 35.42B | 40.60B |
| Cash & ST investments | 5.34B | 7.07B | 7.35B | 6.48B | 6.89B | 8.45B |
| Inventory | 104.10M | 260.50M | 179.50M | 483.70M | 300.10M | 534.80M |
| Total assets | 24.35B | 31.19B | 32.94B | 34.68B | 36.53B | 42.13B |
| Total current liabilities | 21.77B | 27.90B | 29.03B | 30.96B | 32.78B | 37.33B |
| Short-term debt | 5.28B | 6.61B | 6.07B | 7.82B | 8.00B | 8.68B |
| Long-term debt | 1.46B | 2.09B | 2.65B | 2.33B | 2.28B | 2.76B |
| Total liabilities | 23,308,300,000.00 | 30,077,100,000.00 | 31,756,500,000.00 | 33,411,500,000.00 | 35,183,600,000.00 | 40,257,300,000.00 |
| Total equity | 1.05B | 1.11B | 1.18B | 1.26B | 1.35B | 1.87B |
| Retained earnings | 775.30M | 828.20M | 896.70M | 982.00M | 1.08B | 1.20B |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 470.80M | 225.60M | 735.00M | 1.16B | 667.50M |
| Depreciation & amortization | 10.30M | 13.80M | 21.90M | 28.80M | 36.10M |
| Free cash flow | 463.50M | 216.20M | 722.90M | 1.14B | 647.70M |
| Dividends paid | -20.00M | -6.60M | -58.30M | -77.10M | -55.50M |
| Stock buybacks / issuance | 0 | -7.90M | -3.10M | 53.30M | -44.10M |
| Ending cash balance | 712.00M | 910.10M | 1.48B | 2.56B | 2.88B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | 11.83 | 15.86 | 17.61 | 23.36 | 26.23 |
| ROA %i | 1.07 | 0.87 | 0.76 | 0.97 | 1.00 |
| ROIC %i | 4.40 | 5.50 | 7.42 | 9.08 | 9.28 |
| 5-year avg ROE %i | -- | -- | -- | -- | 18.98 |
| EBIT margin %i | 11.31 | 24.39 | 28.34 | 28.81 | 32.28 |
| FCF / sales %i | 54.42 | 18.40 | 30.73 | 39.51 | 17.84 |
| Current ratioi | 0.89 | 1.05 | 1.07 | 1.09 | 1.09 |
| Quick ratioi | 0.63 | 0.84 | 0.78 | 0.68 | 0.67 |
| Debt / assetsi | 24.51 | 36.39 | 30.59 | 25.25 | 29.52 |
| LT debt / equityi | 32.15 | 74.40 | 122.09 | 158.86 | 191.07 |
| Interest coveragei | 3.65 | 1.74 | 1.42 | 1.55 | 1.54 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 50.35 | 45.63 |
| Net income CAGR (3Y) %i | -- | -- | -- | 56.84 | 46.25 |
| FCF CAGR (3Y) %i | -- | -- | -- | 35.13 | 44.16 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 22.33 | 25.18 | 24.85 | 26.23 | 27.87 | 27.57 |
| ROA %i | 0.96 | 1.04 | 1.01 | 1.00 | 1.10 | 1.12 |
| ROIC %i | 8.19 | 9.33 | 3.34 | 9.28 | 9.78 | 9.41 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 28.87 | 30.23 | 28.64 | 32.28 | 31.59 | 32.42 |
| FCF / sales %i | -- | 50.15 | -- | 17.84 | -- | 9.54 |
| Current ratioi | 1.09 | 1.09 | 1.11 | 1.09 | 1.08 | 1.09 |
| Quick ratioi | 0.69 | 0.72 | 0.74 | 0.67 | 0.64 | 0.57 |
| Debt / assetsi | 27.97 | 28.11 | 26.69 | 29.52 | 28.37 | 27.37 |
| LT debt / equityi | 146.83 | 194.35 | 230.99 | 191.07 | 175.21 | 152.35 |
| Interest coveragei | 1.60 | 1.58 | -- | 1.54 | 1.56 | 1.57 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Agency and Execution is the largest reported line at 50.45% of revenue, across 5 reported segments.
- Clearing follows at 23.18%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Agency and Execution50.45%
Clearing23.18%
Market making16.99%
Hedging and Investments solutions10.20%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.